The store will not work correctly when cookies are disabled.
4-(tert-butyl)-N-[5-(4-methoxyphenyl)-1H-pyrazol-3-yl]benzamide
ID: ALA4456566
PubChem CID: 155525381
Max Phase: Preclinical
Molecular Formula: C21H23N3O2
Molecular Weight: 349.43
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(-c2cc(NC(=O)c3ccc(C(C)(C)C)cc3)n[nH]2)cc1
Standard InChI: InChI=1S/C21H23N3O2/c1-21(2,3)16-9-5-15(6-10-16)20(25)22-19-13-18(23-24-19)14-7-11-17(26-4)12-8-14/h5-13H,1-4H3,(H2,22,23,24,25)
Standard InChI Key: SWSYSJWPIQTZEC-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
5.6047 -29.3900 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4219 -29.3900 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6763 -28.6133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0133 -28.1312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3546 -28.6133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4538 -28.3619 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6249 -27.5628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4024 -27.3113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0183 -27.0151 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5795 -28.3637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4103 -27.5631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6338 -27.3108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0258 -27.8582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1996 -28.6610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9758 -28.9096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0072 -27.8603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7842 -27.6094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9558 -26.8096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3444 -26.2610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5698 -26.5148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2482 -27.6070 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.0769 -26.8080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7330 -26.5571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3403 -27.1039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9029 -25.7577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5191 -26.3400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 1 1 0
3 6 1 0
6 7 1 0
7 8 1 0
7 9 2 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
5 10 1 0
8 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 8 1 0
13 21 1 0
21 22 1 0
18 23 1 0
23 24 1 0
23 25 1 0
23 26 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 349.43 | Molecular Weight (Monoisotopic): 349.1790 | AlogP: 4.64 | #Rotatable Bonds: 4 |
Polar Surface Area: 67.01 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.25 | CX Basic pKa: 1.61 | CX LogP: 4.92 | CX LogD: 4.92 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.72 | Np Likeness Score: -1.38 |
References
1. Jumppanen M, Kinnunen SM, Välimäki MJ, Talman V, Auno S, Bruun T, Boije Af Gennäs G, Xhaard H, Aumüller IB, Ruskoaho H, Yli-Kauhaluoma J.. (2019) Synthesis, Identification, and Structure-Activity Relationship Analysis of GATA4 and NKX2-5 Protein-Protein Interaction Modulators., 62 (17): [PMID:31431011] [10.1021/acs.jmedchem.9b01086] |